As a hand surgeon and a coach in a grappling gym, I hear about peptides almost every week. Patients ask about them before surgery. Athletes ask about them after a torn ligament. Someone at the gym swears BPC-157 fixed an elbow that had bothered them for months.
The interest is real, and so is some of the science. The hype is often ahead of the evidence, though. This post covers what we actually know about three of the most popular "healing peptides," what we don't know, and how to think about them if you are recovering from an injury or surgery.
What are peptides?
Peptides are short chains of amino acids, the building blocks of proteins. Your body makes thousands of them, and many act as signals that tell cells what to do. Some well-known medicines are peptides, including insulin and the GLP-1 drugs used for diabetes and weight loss.
The three peptides here are being studied for their effects on tissue repair. None of them has gone through the large clinical trials needed for FDA approval to treat an injury.
BPC-157
What it is: a lab-made 15-amino-acid peptide based on a protein fragment found in human gastric juice.
What the research shows: BPC-157 has been studied mostly in rats. In those models, it has sped up healing of tendon, ligament, muscle, and bone, and it has promoted new blood vessel growth into injured tissue. The animal results are consistent and interesting.
The catch: human data is very limited. A recent systematic review found dozens of preclinical studies and only one clinical study. There are a few small, uncontrolled human reports, such as a retrospective series of patients with knee pain who received injections. There are no randomized controlled trials in people after surgery.
TB-500
What it is: a synthetic fragment of thymosin beta-4. Thymosin beta-4 is a protein your body makes that helps cells migrate to injured areas, form new blood vessels, and calm inflammation.
What the research shows: animal and lab studies suggest benefits for wound healing, muscle injury, and limiting fibrotic scar tissue. For hand and joint surgery, that matters, because stiff scar is a common enemy of a good result.
The catch: most of the human research is on full-length thymosin beta-4, not the TB-500 fragment people actually buy. Those results do not automatically apply to TB-500. As far as I know, there are no published human trials of TB-500 itself.
GHK-Cu (topical copper peptide)
What it is: a small copper-binding peptide found naturally in blood, saliva, and urine. Levels drop with age.
What the research shows: GHK-Cu supports collagen production and skin remodeling. It has the most human data of the three, mostly from skin-care and wound studies. That is why you see it in many serums and creams.
The catch: there is little research on surgical scars specifically. Topical use is the best-supported and lowest-risk way to use it, and it belongs only on skin that has fully healed.
Safety: what I tell my patients
They are optional. No peptide replaces a well-done repair, protection of the healing tissue, and good therapy.
Tell your surgeon first. Do not inject anything near an incision or a fresh repair without clearance.
Skip them if you are pregnant, breastfeeding, or trying to conceive, or if you have active cancer or a history of cancer. Because these peptides may promote blood vessel growth, there is a theoretical concern with cancer.
Athletes, be careful. BPC-157 and TB-500 are prohibited at all times by WADA and banned by USADA, the NCAA, and most professional leagues. A positive test can end a season.
Source matters more than anything. "Research use only" peptides sold online are unregulated. Independent testing has found products that were mislabeled, underdosed, or contaminated. Injecting an unknown powder is a real risk.
Common side effects reported include injection-site redness or irritation, headache, nausea, and lightheadedness. Long-term safety is unknown.
Where things stand legally (as of November 2026)
The rules for compounding pharmacies have changed several times in the last few years:
BPC-157 and TB-500: FDA removed both from its "significant safety concern" list in April 2026. In July 2026, an FDA advisory committee narrowly voted to recommend allowing pharmacies to compound them, although FDA's own scientists had recommended against it. In late October 2026, HHS released a draft policy that would let licensed pharmacies compound single-ingredient versions while formal rulemaking continues. Neither peptide is FDA-approved.
GHK-Cu: non-injectable forms, such as topical creams, are in the category FDA allows pharmacies to compound while it continues its review.
What this means for you: if you are going to use a peptide, it should be prescribed by a licensed clinician after a real medical evaluation and prepared by a licensed U.S. pharmacy.
What actually helps you heal
Before spending money on any peptide, make sure the basics are covered. They have far more evidence behind them:
No nicotine in any form. It is one of the strongest predictors of poor wound, tendon, and bone healing.
Protect the repair and do your therapy. Most bad outcomes I see come from doing too much too soon, or too little for too long.
Eat enough protein throughout the day.
Sleep 7 to 9 hours. Tissue repair happens during sleep.
Control blood sugar and limit alcohol.
Interested in peptides?
At Flos Health, we offer physician-led telehealth consultations for patients who want to explore peptide therapy. We review your history, your injury or surgery, your goals, and whether you compete in tested sports. Then we give you an honest recommendation, which sometimes is "not for you." When a peptide is appropriate and allowed under current rules, prescriptions are filled only by licensed U.S. compounding pharmacies.
Book a consultation at flosrx.com
Disclosure: Dr. Khan is co-founder and co-owner of Flos Health and has a financial interest in it.
This article is for education only and is not medical advice. BPC-157 and TB-500 are not FDA-approved to treat any condition. Compounded drugs are not FDA-approved. Talk with your own physician before starting any treatment.
References
Gwyer D, Wragg NM, Wilson SL. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res. 2019;377:153-159.
Seiwerth S, Rucman R, Turkovic B, et al. BPC 157 and standard angiogenic growth factors. Gastrointestinal tract healing, lessons from tendon, ligament, muscle and bone healing. Curr Pharm Des. 2018;24:1972-1989.
Lee E, Padgett B. Intra-articular injection of BPC 157 for multiple types of knee pain. Altern Ther Health Med. 2021;27(4):8-13.
Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987.
DeFoor MT, Dekker TJ. Arthroscopy. 2024. doi:10.1016/j.arthro.2024.09.005.
U.S. Food and Drug Administration. Bulk drug substances nominated for use in compounding under section 503A (updated May 14, 2026).
World Anti-Doping Agency. Prohibited List, Section S0: Non-approved substances.
